Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-12FDA Approved: VOGELXO — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Vogelxo (testosterone) submitted by Upsher-Smith Laboratories, LLC. The approval relates to chan…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) [Phase 3]
Phase 3 trial evaluating corifollitropin alfa in combination with hCG for adult men with hypogonadotropic hypogonadism; the study is complet…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. [Phase 2]
Phase 2 randomized trial comparing aromatase inhibition versus testosterone in older men with low testosterone; results completed with poste…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Hormone Treatment in Growth Hormone and Testosterone Deficient Patients [Phase 2]
A Phase 2 trial of a hormone treatment for growth hormone deficiency and testosterone deficiency was terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Oral Testosterone for the Treatment of Hypogonadism [Phase 2]
Phase 2 clinical trial evaluating oral testosterone for hypogonadism has completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815) [Phase 2]
A Phase 2 study evaluating a measure of symptoms in older men with low testosterone during on- and off testosterone replacement therapy was …
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men [Phase 2]
Phase 2 safety and efficacy study of oral fispemifene for sexual dysfunction in men with secondary hypogonadism; the status of the trial is …
-
FDA approval · 2015-11-05FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for TESTOSTERONE from Actavis Pharma, Inc., authorizing changes to the product labeling.
-
FDA approval · 2015-10-28FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for TESTOSTERONE from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism [Phase 4]
Phase 4 MRI substudy examining metabolic changes related to iatrogenic hypogonadism in patients with prostate cancer and metabolic syndrome;…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Pharmacokinetic Study of Testosterone Enanthate [Phase 1, Phase 2]
Phase 1/2 pharmacokinetic study of testosterone enanthate completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy [Phase 3]
A Phase 3 study evaluated a testosterone solution in men with hypogonadism. It measured testosterone levels, libido, and energy, and the tri…
-
FDA approval · 2015-09-25FDA Approved: TESTOSTERONE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's supplemental application for testosterone.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) [Phase 2]
Phase 2 trial comparing Androxal to AndroGel for morning testosterone in men with secondary hypogonadism; results have been posted.
-
FDA approval · 2015-09-21FDA Approved: METHYLTESTOSTERONE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approves Amneal Pharmaceuticals of New York LLC for methyltestosterone as an Original Application (generic) to bring a generic version o…
-
FDA approval · 2015-09-08FDA Approved: TESTOSTERONE ENANTHATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for testosterone enanthate from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2015-08-25FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA granted supplemental approval for testosterone cypionate from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-08-17FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
The FDA approved a supplemental application for AndroGel (testosterone) from ASCEND Therapeutics U.S., LLC.
-
FDA approval · 2015-08-17FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for testosterone filed by Prasco Laboratories under NDA 022309. This action grants supplemental appr…
-
CLINICAL_TRIALS withdrawal · 2015-08-10Clinical Trial Update: Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes [Phase 4]
A Phase 4 trial investigating testosterone gel replacement for fat mass in men with hypogonadism and diabetes has been withdrawn.
-
FDA approval · 2015-08-04FDA Approved: TESTOSTERONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approves Padagis Israel Pharmaceuticals Ltd's original application for a generic testosterone product. This approval authorizes test…
-
FDA approval · 2015-07-22FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for TESTOSTERONE CYPIONATE by Padagis US LLC, indicating approval of a supplemental submission for t…
-
FDA approval · 2015-06-30FDA Approved: TESTOSTERONE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for TESTOSTERONE (TESTOSTERONE) submitted by Strides Pharma Science Limited, marking an update t…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Testosterone for Penile Rehabilitation After Radical Prostatectomy [EARLY_Phase 1]
An early-phase 1 trial of testosterone for penile rehabilitation after radical prostatectomy was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism [Phase 3]
Phase III trial evaluating morning testosterone normalization in men with secondary hypogonadism has completed, with results posted in 2015.